New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
17:55 EDTMNK, QCORQuestcor's Acthar risks not included in Mallinckrodt's merger proxy, NYT says
Risks regarding the increase of adverse events related to Questcor's (QCOR) drug Acthar need to be considered by Mallinckrodt's (MNK) shareholders. Those risks were not included in last month's merger proxy, reports the New York Times. Reference Link
News For MNK;QCOR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 27, 2014
07:23 EDTMNKAmerican College of Surgeons holds a conference
Subscribe for More Information
October 23, 2014
10:01 EDTMNKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:20 EDTMNKMallinckrodt initiated with a Buy at Guggenheim
Subscribe for More Information
October 20, 2014
07:12 EDTMNKCongress of Neurological Surgeons to hold annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use